51 results on '"HAKIM, Raymond"'
Search Results
2. Dialysate and Serum Potassium in Hemodialysis
3. First-Year Outcomes of Incident Peritoneal Dialysis Patients in the United States
4. Oral Protein Supplementation Alone Improves Anabolism in a Dose-Dependent Manner in Chronic Hemodialysis Patients
5. Association Between Achievement of Hemodialysis Quality-of-Care Indicators and Quality-of-Life Scores
6. Change in Vascular Access and Mortality in Maintenance Hemodialysis Patients
7. Hemodialysis Facility–Based Quality-of-Care Indicators and Facility-Specific Patient Outcomes
8. Associates of Mortality and Hospitalization in Hemodialysis: Potentially Actionable Laboratory Variables and Vascular Access
9. The Association of Race With Erythropoietin Dose in Patients on Long-term Hemodialysis
10. Potential Impact of Nutritional Intervention on End-Stage Renal Disease Hospitalization, Death, and Treatment Costs
11. Balancing Fistula First With Catheters Last
12. The extent of uremic malnutrition at the time of initiation of maintenance hemodialysis is associated with subsequent hospitalization
13. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
14. Inflammatory signals associated with hemodialysis
15. Therapeutic effects of oral nutritional supplementation during hemodialysis
16. Urea volume of distribution exceeds total body water in patients with acute renal failure
17. Vascular access blood flow monitoring reduces access morbidity and costs
18. Serum transferrin and serum prealbumin are early predictors of serum albumin in chronic hemodialysis patients
19. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study
20. Measurement of the delivery of dialysis in acute renal failure
21. Increased susceptibility to erythrocyte C5b-9 deposition and complement-mediated lysis in chronic renal failure
22. In Reply to ‘Dialysate and Serum Potassium in Hemodialysis’
23. Post-Hospital Rapid Anemia Management Reduces Rate of Readmission: The Rightreturn Program
24. Recombinant human growth hormone in patients with acute renal failure
25. Anabolic Interventions in ESRD: Light at the End of the Tunnel?
26. 100: HD Catheters and Inflammation are Determinants of Erythropoietin (EPO) Requirements
27. Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective
28. 23: Trends in Parathyroid Hormone (PTH) in Hemodiaysis (HD) Patients (PTS)
29. Obesity and mortality in ESRD: Is it good to be fat?
30. Chapter 18 Complement activation by biomaterials
31. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors
32. Defective platelet aggregation in uremia is transiently worsened by hemodialysis
33. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin
34. Hemodialysis access failure: A call to action
35. Change in access blood flow over time predicts vascular access thrombosis
36. Predictive measures of vascular access thrombosis: A prospective study
37. Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients
38. Effect of the dialysis membrane on mortality of chronic hemodialysis patients
39. The dose of hemodialysis and patient mortality
40. Nutrition in end-stage renal disease
41. Effects of recombinant human growth hormone on plasma and dialysate amino acid profiles in CAPD patients
42. Short-term effects of recombinant human growth hormone in CAPD patients
43. Amino acid and albumin losses during hemodialysis
44. Anti-platelet therapy in graft thrombosis: Results of a prospective, randomized, double-blind study
45. Natural killer-cell function in hemodialysis patients: Effect of the dialysis membrane
46. Modulation of granulocyte LAM-1 and MAC-1 during dialysis—A prospective, randomized controlled trial
47. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression
48. Phagocytosis in uremic and hemodialysis patients: A prospective and cross sectional study
49. Hemodialysis-associated platelet activation and thrombocytopenia
50. Interventions to treat malnutrition in dialysis patients: The role of the dose of dialysis, intradialytic parenteral nutrition, and growth hormone
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.